EDESA BIOTECH, INC. Contractual Obligation, to be Paid, Year Five
EDESA BIOTECH, INC. (EDSA) had Contractual Obligation, to be Paid, Year Five of $0 as of 2025-09-30, per its 10-K filed 2025-12-12.
Financial Statements › Notes › Commitment and Contingencies › Contractual Obligation, Fiscal Year Maturity › Contractual Obligation, to be Paid, Year Four and Five
us-gaap:ContractualObligationDueInFifthYear · last filed 2025-12-12
- 2025-09-30: Contractual Obligation, to be Paid, Year Five $0.00.
- 2024-09-30: Contractual Obligation, to be Paid, Year Five $0.00.
- 2024-03-31: Contractual Obligation, to be Paid, Year Five $0.00.
- 2023-12-31: Contractual Obligation, to be Paid, Year Five $0.00.
| Period end | Contractual Obligation, to be Paid, Year Five |
|---|---|
| 2025-09-30 | $0.00 10-K · filed 2025-12-12 |
| 2024-09-30 | $0.00 10-K · filed 2024-12-13 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-10 |
| 2023-12-31 | $0.00 10-Q · filed 2024-02-09 |
| 2023-06-30 | $49.00B 10-K · filed 2023-12-15 |
| 2023-03-31 | $48.00B 10-Q · filed 2023-05-11 |
| 2022-12-31 | $47.00B 10-Q · filed 2023-02-10 |
| 2022-09-30 | $50.00B 10-K · filed 2022-12-16 |
| 2020-06-30 | $23.00K 10-Q · filed 2020-08-12 |
| 2019-06-30 | $35.00K 10-Q · filed 2019-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |